Results 41 to 50 of about 67,556 (137)

Applications of Microarray Technology to Acute Myelogenous Leukemia

open access: yes, 2009
Microarray technology is a powerful tool, which has been applied to further the understanding of gene expression changes in disease. Array technology has been applied to the diagnosis and prognosis of Acute Myelogenous Leukemia (AML).
Mahadeo A. Sukhai   +4 more
core  

Supplementary Tables S1-S6 from NF1 Inactivation in Adult Acute Myelogenous Leukemia

open access: yes, 2010
Supplementary Tables S1-S6 from NF1 Inactivation in Adult Acute Myelogenous ...
Yin Wang (34938)   +18 more
core   +1 more source

Management of imatinib-resistant CML patients [PDF]

open access: yes, 2007
Imatinib has had marked impact on outcomes in chronic myelogenous leukemia (CML) patients for all stages of the disease and is endorsed by international treatment guidelines as the first line option.
Dempke, Wolfram, Linke, Rolf
core   +1 more source

Charge‐Transfer‐Engineered Organic/2D Hybrid Interface for Programmable SERS and Emerging Biosensing Applications

open access: yesAggregate, Volume 7, Issue 11, November 2026.
Organic/2D hybrid interfaces provide a route to regulate interfacial charge transfer and enhance surface‐enhanced Raman spectroscopy (SERS). This review links energy‐level alignment, charge transfer, excitonic interactions, and fluorescence quenching to improved signal enhancement and reproducibility, outlining materials‐design strategies for sensitive,
Abdur Rahim   +11 more
wiley   +1 more source

Chronic Myelogenous Leukemia

open access: yes, 2002
Chronic Myelogenous ...
Lawrence, Christine
core  

CCR Translation for This Article from NF1 Inactivation in Adult Acute Myelogenous Leukemia

open access: yes, 2010
CCR Translation for This Article from NF1 Inactivation in Adult Acute Myelogenous ...
Yin Wang (34938)   +18 more
core   +1 more source

Lineage switch in childhood leukemia

open access: yesHemaSphere, Volume 10, Issue 11, November 2026.
Abstract Lineage switch (LS) is a rare but aggressive immunophenotypic transformation of acute leukemia associated with limited therapeutic options and poor clinical outcome. Although LS has been increasingly recognized in the era of CD19‐directed immunotherapies, its biological basis remains incompletely understood.
Katharina Daugs   +3 more
wiley   +1 more source

Supplementary Table S8 from NF1 Inactivation in Adult Acute Myelogenous Leukemia

open access: yes, 2010
Supplementary Table S8 from NF1 Inactivation in Adult Acute Myelogenous ...
Yin Wang (34938)   +18 more
core   +1 more source

Exhaled Breath Condensate‐Derived Extracellular Vesicles Isolated via Nanobody‐SpyTag3 Fusion Proteins Enable Lung Cancer Diagnosis

open access: yesJournal of Extracellular Vesicles, Volume 15, Issue 11, November 2026.
Engineered nanobodies immunoisolate extracellular vesicles (EVs) from exhaled breath condensate (EBC) for lung cancer liquid biopsy. Pilot data indicate EBC‐derived EVs improve detection of early‐stage, central‐type lung cancer, whereas plasma EVs perform better for advanced, peripheral‐type disease, supporting a stage‐ and location‐stratified ...
Xiaohong Lyu   +9 more
wiley   +1 more source

Supplementary Figures S1-S2 from NF1 Inactivation in Adult Acute Myelogenous Leukemia

open access: yes, 2010
Supplementary Figures S1-S2 from NF1 Inactivation in Adult Acute Myelogenous ...
Yin Wang (34938)   +18 more
core   +1 more source

Home - About - Disclaimer - Privacy